Biopharmaceutical

R&D

JP Morgan 2023 – Claudia Ulbrich

On Wednesday of JP Morgan week last month, pharmaphorum editor-in-chief Jonah Comstock sat down at the Zeppelin Hotel with Claudia Ulbrich, CEO of Germany-based Cardior, to learn a little more abou

Partner Content

Partner Content

Report: Reinventing product and portfolio value for the biop...

Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing ne

News

Deals build Fresenius Kabi's position in biosimilars, medtec...

German injectable medicines specialist Fresenius Kabi has made a pair of deals to kickstart its new strategic direction, including a majority stake in mAbxience that bolsters its position i

Partner Content

Partner Content

Highly Potent Active Pharmaceutical Ingredients Conference H...

The Highly Potent Active Pharmaceutical Ingredients conference will be hosting 2 interactive half day post-conference workshops on the 23rd May, presented by HPAPI Project Services Limited

Events

Partner Content

2018 Off-Label Regulatory Compliance Congress

As the demand for information outside of approved labeling continues to rise, the FDA has been called by the industry to provide guidance that governs off-label communications.

Partner Content